Helen Sheridan
Corporate Officer/Principal presso Irish Medicines Board
Profilo
Helen Sheridan is the founder of Trino Therapeutics Ltd., which was founded in 1999.
She held the title of Principal Chemist & IP Specialist from 1999 to 2012.
Currently, she is a Member of the Irish Medicines Board.
Dr. Sheridan received a doctorate degree from University College Dublin.
Posizioni attive di Helen Sheridan
| Società | Posizione | Inizio |
|---|---|---|
| Irish Medicines Board | Corporate Officer/Principal | - |
Precedenti posizioni note di Helen Sheridan
| Società | Posizione | Fine |
|---|---|---|
Trino Therapeutics Ltd.
 Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Fondatore | - |
Formazione di Helen Sheridan
| University College Dublin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Health Technology |
| Irish Medicines Board |
- Borsa valori
- Insiders
- Helen Sheridan
